| Treatment of metastatic melanoma with an autologous tumor-cell vaccine: clinical and immunologic results in 64 patients. D Berd, HC Maguire Jr, P McCue, MJ Mastrangelo Journal of clinical oncology 8 (11), 1858-1867, 1990 | 407 | 1990 |
| Induction of cell-mediated immunity to autologous melanoma cells and regression of metastases after treatment with a melanoma cell vaccine preceded by cyclophosphamide D Berd, HC Maguire Jr, MJ Mastrangelo Cancer Research 46 (5), 2572-2577, 1986 | 347 | 1986 |
| Rarity of Somatic and Germline Mutations of the Cyclin-dependent Kinase 4 Inhibitor Gene, CDK4I, in Melanoma M Ohta, H Nagai, M Shimizu, D Rasio, D Berd, M Mastrangelo, AD Singh, ... Cancer research 54 (20), 5269-5272, 1994 | 226 | 1994 |
| Effect of low dose cyclophosphamide on the immune system of cancer patients: depletion of CD4+, 2H4+ suppressor-inducer T-cells D Berd, MJ Mastrangelo Cancer research 48 (6), 1671-1675, 1988 | 209 | 1988 |
| Regulation of intracellular pH in human melanoma: potential therapeutic implications ML Wahl, JA Owen, R Burd, RA Herlands, SS Nogami, U Rodeck, D Berd, ... Molecular cancer therapeutics 1 (8), 617-628, 2002 | 188 | 2002 |
| Augmentation of the human immune response by cyclophosphamide D Berd, MJ Mastrangelo, PF Engstrom, A Paul, H Maguire Cancer Research 42 (11), 4862-4866, 1982 | 186 | 1982 |
| Potentiation of human cell-mediated and humoral immunity by low-dose cyclophosphamide D Berd, HC Maguire Jr, MJ Mastrangelo Cancer research 44 (11), 5439-5443, 1984 | 177 | 1984 |
| Immunopharmacologic analysis of an autologous, hapten-modified human melanoma vaccine D Berd, T Sato, HC Maguire Jr, J Kairys, MJ Mastrangelo Journal of clinical oncology 22 (3), 403-415, 2004 | 172 | 2004 |
| Autologous hapten-modified melanoma vaccine as postsurgical adjuvant treatment after resection of nodal metastases. D Berd, HC Maguire Jr, LM Schuchter, R Hamilton, WW Hauck, T Sato, ... Journal of clinical oncology 15 (6), 2359-2370, 1997 | 172 | 1997 |
| Effective combination chemo/hormonal therapy for malignant melanoma: experience with three consecutive trials EF McCiay, MJ Mastrangelo, D Berd, RE Bellet International journal of cancer 50 (4), 553-556, 1992 | 166 | 1992 |
| Abnormal expression of perlecan proteoglycan in metastatic melanomas IR Cohen, AD Murdoch, MF Naso, D Marchetti, D Berd, RV Iozzo Cancer research 54 (22), 5771-5774, 1994 | 162 | 1994 |
| Interleukin 10 production by human melanoma. T Sato, P McCue, K Masuoka, S Salwen, EC Lattime, MJ Mastrangelo, ... Clinical cancer research: an official journal of the American Association …, 1996 | 159 | 1996 |
| Protracted survival after resection of metastatic uveal melanoma T Aoyama, MJ Mastrangelo, D Berd, FE Nathan, CL Shields, JA Shields, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2000 | 150 | 2000 |
| Combination Chemotherapy and Hormonal Therapy in the Treatment of Malignant Melanoma 1, 2 EF McClay, MJ Mastrangelo, RE Bellet, D Berd Cancer treatment reports 71 (5), 465, 1987 | 143 | 1987 |
| Chemoembolization of the hepatic artery with BCNU for metastatic uveal melanoma: results of a phase II study K Patel, K Sullivan, D Berd, MJ Mastrangelo, CL Shields, JA Shields, ... Melanoma research 15 (4), 297-304, 2005 | 135 | 2005 |
| Effect of low dose cyclophosphamide on the immune system of cancer patients: reduction of T-suppressor function without depletion of the CD8+ subset D Berd, MJ Mastrangelo Cancer research 47 (12), 3317-3321, 1987 | 132 | 1987 |
| The importance of tamoxifen to a cisplatin‐containing regimen in the treatment of metastatic melanoma EF McClay, MJ Mastrangelo, JD Sprandio, RE Bellet, D Berd Cancer 63 (7), 1292-1295, 1989 | 131 | 1989 |
| Long‐term remission in diffuse histiocytic lymphoma treated with combination sequential chemotherapy D Berd, J Cornog, RC Deconti, M Levitt, JR Bertino Cancer 35 (4), 1050-1054, 1975 | 130 | 1975 |
| Effects of anticancer drugs on the immune system in humans. MJ Ehrke, E Mihich, D Berd, MJ Mastrangelo Seminars in oncology 16 (3), 230-253, 1989 | 123 | 1989 |
| Deletion mapping of chromosome region 9p21‐p22 surrounding the CDKN2 locus in melanoma M Ohta, D Berd, M Shimizu, H Nagai, MG Cotticelli, M Mastrangelo, ... International journal of cancer 65 (6), 762-767, 1996 | 113 | 1996 |
